MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Alector Shares 2011-2026 | ALEC
Annual Shares Alector
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 M | 96.6 M | 83.7 M | 82.5 M | 80.4 M | 77.8 M | 61.7 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 103 M | 61.7 M | 83.7 M |
Quarterly Shares Alector
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 M | 100 M | 99.4 M | 99.1 M | 97.5 M | 96.7 M | 93.8 M | 84.9 M | 83.9 M | 83.5 M | 83.1 M | 82.9 M | 82.6 M | 82.4 M | 82.1 M | 82 M | 81 M | 80 M | 79.4 M | 79.3 M | 78.8 M | 78.4 M | 74.8 M | 69.1 M | 67.6 M | 67.3 M | 43.8 M | 13.8 M | 11.4 M | 11.2 M | 10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 M | 10.9 M | 73.7 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
126 M | $ 20.32 | -1.86 % | $ 2.56 B |  USA |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 0.82 | -2.7 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
49.7 M | $ 165.39 | -0.6 % | $ 8.23 B | USA |
 |
I-Mab
IMAB
|
187 M | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
299 M | $ 3.65 | -4.58 % | $ 1.09 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
219 M | $ 8.35 | -4.41 % | $ 1.4 B | Britain |
 |
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Corvus Pharmaceuticals
CRVS
|
48 M | $ 17.24 | -3.63 % | $ 828 M | USA |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
26.8 M | $ 25.62 | -4.62 % | $ 686 M | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | Canada |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Codexis
CDXS
|
73.4 M | $ 0.99 | -2.59 % | $ 72.7 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
358 K | $ 3.18 | -4.94 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
58 M | $ 28.47 | -2.5 % | $ 1.65 B | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
44.8 M | $ 3.64 | -4.21 % | $ 116 M | France |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
71 M | $ 4.15 | -0.24 % | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
5.59 M | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
12.3 M | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
122 M | $ 24.06 | 0.75 % | $ 2.94 B | USA |
 |
Amarin Corporation plc
AMRN
|
415 M | $ 13.95 | 0.14 % | $ 5.79 B |  Irlanda |
 |
AbbVie
ABBV
|
1.77 B | $ 231.93 | -0.98 % | $ 410 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
62.9 M | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |